Preparation, Characterization, and Anticancer Effects of Capsaicin-Loaded Nanoliposomes

Overview

Journal Nutrients

Date 2021 Nov 27

PMID 34836251

Citations 12

Authors

Ali Al-Samydai

Walhan Alshaer

Emad A S Al-Dujaili

Hanan Azzam

Talal Aburjai

Affiliations

Soon will be listed here.

Abstract

Background: Medicinal plants have proven their value as a source of molecules with therapeutic potential, and recent studies have shown that capsaicin has profound anticancer effects in several types of human cancers. However, its clinical use is handicapped due to its poor pharmacokinetics. This study aims to enhance capsaicin's pharmacokinetic properties by loading the molecule into nanoliposomes model and testing its anticancer activity.

Methods: Nanoliposomes were prepared using the thin-film method, and characteristics were examined followed by qualitative and quantitative analyses of encapsulation efficiency and drug loading using HPLC at different lipid/capsaicin ratios. Cell viability assay (MTT) was used to determine IC.

Results: Capsaicin-loaded nanoliposomes showed optimum characteristics of morphology, particle size, zeta potential, and stability. In vitro anticancer activity of capsaicin and capsaicin-loaded nanoliposomes were compared against MCF7, MDA-MB-231, K562, PANC1, and A375 cell lines. Capsaicin-loaded nanoliposomes showed significant improvement in anticancer activity against cancers cell lines studied ( < 0.001), with increased selectivity against cancer cells compared to capsaicin.

Conclusion: The encapsulated capsaicin nanoliposomes produced an improvement in pharmacokinetics properties, enhancing the anticancer activity and selectivity compared with capsaicin. This model seems to offer a potential for developing capsaicin formulations for the prevention and treatment of cancer.

Citing Articles

PEGylated Nanoliposomes Encapsulated with Anticancer Drugs for Breast and Prostate Cancer Therapy: An Update.

Peter S, Khwaza V, Alven S, Naki T, Aderibigbe B Pharmaceutics. 2025; 17(2).

PMID: 40006557 PMC: 11859135. DOI: 10.3390/pharmaceutics17020190.

Oxyresveratrol as a novel ferroptosis inducer exhibits anticancer activity against breast cancer via the EGFR/PI3K/AKT/GPX4 signalling axis.

Xiang L, Li Q, Guan Z, Wang G, Yu X, Zhang X Front Pharmacol. 2025; 15:1527286.

PMID: 39881871 PMC: 11775479. DOI: 10.3389/fphar.2024.1527286.

Preparation, characterization, and anticancer effect of Capsaicin-functionalized selenium nanoparticles.

Tang E, Ma Z, Zhang P, Chen Y, Zhou Y, Wu J Front Nutr. 2025; 11:1515657.

PMID: 39758309 PMC: 11695334. DOI: 10.3389/fnut.2024.1515657.

Optimization of Instant Beverage Powder Containing Propolis Extract Nanoliposomes.

Mirzazadeh M, Bagheri H, Rasi F, Mirzazadeh N, Alam Z, Akhavan-Mahdavi S Int J Food Sci. 2024; 2024:9099501.

PMID: 39687482 PMC: 11649347. DOI: 10.1155/ijfo/9099501.

Capsaicin Exerts Antitumor Activity in Mesothelioma Cells.

Andretta E, Costa A, Ventura E, Quintiliani M, Damiano S, Giordano A Nutrients. 2024; 16(21).

PMID: 39519591 PMC: 11547426. DOI: 10.3390/nu16213758.

References

Alshaer W, Zraikat M, Amer A, Nsairat H, Lafi Z, Alqudah D . Encapsulation of echinomycin in cyclodextrin inclusion complexes into liposomes: anti-proliferative and anti-invasive activity in glioblastoma. RSC Adv. 2022; 9(53):30976-30988. PMC: 9072562. DOI: 10.1039/c9ra05636j. View

Wieduwilt M, Moasser M . The epidermal growth factor receptor family: biology driving targeted therapeutics. Cell Mol Life Sci. 2008; 65(10):1566-84. PMC: 3060045. DOI: 10.1007/s00018-008-7440-8. View

Cragg G, Newman D . Plants as a source of anti-cancer agents. J Ethnopharmacol. 2005; 100(1-2):72-9. DOI: 10.1016/j.jep.2005.05.011. View

Zhang S, Wang D, Huang J, Hu Y, Xu Y . Application of capsaicin as a potential new therapeutic drug in human cancers. J Clin Pharm Ther. 2019; 45(1):16-28. DOI: 10.1111/jcpt.13039. View

Zylberberg C, Matosevic S . Pharmaceutical liposomal drug delivery: a review of new delivery systems and a look at the regulatory landscape. Drug Deliv. 2016; 23(9):3319-3329. DOI: 10.1080/10717544.2016.1177136. View

Li C, Zhang J, Zu Y, Nie S, Cao J, Wang Q . Biocompatible and biodegradable nanoparticles for enhancement of anti-cancer activities of phytochemicals. Chin J Nat Med. 2015; 13(9):641-52. PMC: 5488276. DOI: 10.1016/S1875-5364(15)30061-3. View

Abdelnabi H, Alshaer W, Azzam H, Alqudah D, Al-Samydai A, Aburjai T . Loading of capsaicin-in-cyclodextrin inclusion complexes into PEGylated liposomes and the inhibitory effect on IL-8 production by MDA-MB-231 and A549 cancer cell lines. Z Naturforsch C J Biosci. 2021; 76(11-12):503-514. DOI: 10.1515/znc-2021-0018. View

Pelicano H, Carney D, Huang P . ROS stress in cancer cells and therapeutic implications. Drug Resist Updat. 2004; 7(2):97-110. DOI: 10.1016/j.drup.2004.01.004. View

Krol M, Pawlowski K, Majchrzak K, Szyszko K, Motyl T . Why chemotherapy can fail?. Pol J Vet Sci. 2010; 13(2):399-406. View

10.

Zhu Y, Wang M, Zhang J, Peng W, Firempong C, Deng W . Improved oral bioavailability of capsaicin via liposomal nanoformulation: preparation, in vitro drug release and pharmacokinetics in rats. Arch Pharm Res. 2014; 38(4):512-21. DOI: 10.1007/s12272-014-0481-7. View

11.

Giri T, Giri A, Barman T, Maity S . Nanoliposome is a Promising Carrier of Protein and Peptide Biomolecule for the Treatment of Cancer. Anticancer Agents Med Chem. 2015; 16(7):816-31. DOI: 10.2174/1871520616666151116121821. View

12.

Zargar A, Chang S, Kothari A, Snijders A, Mao J, Wang J . Overcoming the challenges of cancer drug resistance through bacterial-mediated therapy. Chronic Dis Transl Med. 2020; 5(4):258-266. PMC: 7004931. DOI: 10.1016/j.cdtm.2019.11.001. View

13.

Bley K, Boorman G, Mohammad B, McKenzie D, Babbar S . A comprehensive review of the carcinogenic and anticarcinogenic potential of capsaicin. Toxicol Pathol. 2012; 40(6):847-73. DOI: 10.1177/0192623312444471. View

14.

Samad A, Sultana Y, Aqil M . Liposomal drug delivery systems: an update review. Curr Drug Deliv. 2007; 4(4):297-305. DOI: 10.2174/156720107782151269. View

15.

Zarrabi A, Alipoor Amro Abadi M, Khorasani S, Mohammadabadi M, Jamshidi A, Torkaman S . Nanoliposomes and Tocosomes as Multifunctional Nanocarriers for the Encapsulation of Nutraceutical and Dietary Molecules. Molecules. 2020; 25(3). PMC: 7037994. DOI: 10.3390/molecules25030638. View

16.

Kreso A, Dick J . Evolution of the cancer stem cell model. Cell Stem Cell. 2014; 14(3):275-91. DOI: 10.1016/j.stem.2014.02.006. View

17.

Mousavi S, Moallem S, Mehri S, Shahsavand S, Nassirli H, Malaekeh-Nikouei B . Improvement of cytotoxic and apoptogenic properties of crocin in cancer cell lines by its nanoliposomal form. Pharm Biol. 2011; 49(10):1039-45. DOI: 10.3109/13880209.2011.563315. View

18.

Ventola C . Progress in Nanomedicine: Approved and Investigational Nanodrugs. P T. 2017; 42(12):742-755. PMC: 5720487. View

19.

Rollyson W, Stover C, Brown K, Perry H, Stevenson C, McNees C . Bioavailability of capsaicin and its implications for drug delivery. J Control Release. 2014; 196:96-105. PMC: 4267963. DOI: 10.1016/j.jconrel.2014.09.027. View

20.

Alshaer W, Hillaireau H, Fattal E . Aptamer-guided nanomedicines for anticancer drug delivery. Adv Drug Deliv Rev. 2018; 134:122-137. DOI: 10.1016/j.addr.2018.09.011. View